CTXR · Company research
Citius Pharmaceuticals Inc. Common (CTXR): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Citius Pharmaceuticals (CTXR) Falls 5.12% to $0.55, Testing Support Near $0.52 - Low Risk Entry Stocks - https://www.siam.in/ | Citius Pharmaceuticals (CTXR) Falls 5.12% to $0.55, Testing Support Near $0.52 - Low Risk Entry Stocks https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Sep 29, 2026 | neutral | 0 | 0.6 |
| CTXR Q4 2025 Earnings: Wider-Than-Expected Loss Sends Shares Lower - Banking Earnings Report - https://www.dars.gov.et/ | CTXR Q4 2025 Earnings: Wider-Than-Expected Loss Sends Shares Lower - Banking Earnings Report https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Sep 28, 2026 | neutral | 0 | 0.6 |
| CTXR News | CITIUS PHARMACEUTICALS INC (NASDAQ:CTXR) - ChartMill | CTXR News | CITIUS PHARMACEUTICALS INC (NASDAQ:CTXR) ChartMill | View source ↗ | ChartMill | Sep 19, 2026 | neutral | 0 | 0.6 |
| Citius Pharmaceuticals Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView | Citius Pharmaceuticals Disclosed Failure to Satisfy a Continued Listing Rule or Standard TradingView | View source ↗ | TradingView | Aug 21, 2026 | neutral | 0 | 0.6 |
| CTXR Forecast — Price Target — Prediction for 2027 - TradingView | CTXR Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Breakeven On The Horizon For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Simply Wall Street | Breakeven On The Horizon For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Simply Wall Street | View source ↗ | Simply Wall Street | May 28, 2026 | neutral | 0 | 0.6 |
| Is Citius Pharmaceuticals, Inc. (CTXR) among the Best Rated Penny Stocks to Buy According to Wall Street Analysts? - Yahoo Finance | Is Citius Pharmaceuticals, Inc. (CTXR) among the Best Rated Penny Stocks to Buy According to Wall Street Analysts? Yahoo Finance | View source ↗ | Yahoo Finance | May 24, 2026 | neutral | 0 | 0.6 |
| Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update - PR Newswire | Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update PR Newswire | View source ↗ | PR Newswire | May 15, 2026 | neutral | 0 | 0.6 |
| What's Behind The Drop In Citius Pharmaceuticals? - Benzinga | What's Behind The Drop In Citius Pharmaceuticals? Benzinga | View source ↗ | Benzinga | Apr 24, 2026 | neutral | 0 | 0.6 |
| Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules - PR Newswire | Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules PR Newswire | View source ↗ | PR Newswire | Apr 24, 2026 | neutral | 0 | 0.6 |
| We Might See A Profit From Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Soon - Yahoo Finance | We Might See A Profit From Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Soon Yahoo Finance | View source ↗ | Yahoo Finance | Apr 21, 2026 | neutral | 0 | 0.6 |
| CTXR Should I Buy - Intellectia AI | CTXR Should I Buy Intellectia AI | View source ↗ | Intellectia AI | Feb 28, 2026 | neutral | 0 | 0.6 |
| Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™ - PR Newswire | Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™ PR Newswire | View source ↗ | PR Newswire | Feb 13, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Jan 12, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.